1) Fletcher CDM, Unni KK (eds):Pathology and genetics:Tumours of Soft Tissue and Bone. World Health Organization Classification of Tumors. Lyon:IARC Press 35-46:2002
2) Gaskin CM, Helms CA:Lipomas, lipoma variants, and well-differentiated liposarcomas (atypical lipomas):results of MRI evaluations of 126 consecutive fatty masses. AJR Am J Roentgenol 182:733-739, 2004
3) 堀江直行,坂部智哉,村田博昭・他:高分化型治療肉腫の治療成績.日整会誌80;S625,2006
4) 石谷邦彦,村上俊吾,岸 昭彦:高齢者癌治療におけるQuality of life.癌と化学療法19:1808-1816,1992
5) 川上泰雄:サルコペニア.研究の現状と臨床への応用.高齢者の骨格筋の形態と機能.Geriat Med 48:227-230,2010
6) 厚生労働省国民生活基礎調査室:介護が必要となった主な原因.第15表.平成22年国民生活基礎調査.2010 http://www.e-stat.go.jp/SG1/estat/GL08020103.do?toGL08020103&listID=000001083953&requestSender=dsearch
7) 森岡秀夫,矢部啓夫,穴澤卯圭・他:高齢者発生軟部肉腫の治療戦略.骨・関節・靱帯17:293-299,2004
8) Nakamura K:The concept and treatment of locomotive syndrome:its acceptance and spread in Japan. J Orthop Sci 16:489-491, 2011
9) 日本整形外科学会骨・軟部腫瘍委員会,国立がん研究センター(編).全国骨・軟部腫瘍登録一覧表.平成21年度,2009
10) Smith CA, Martinez SR, Tseng WH, et al:Predicting survival for well-differentiated liposarcoma:The importance of tumor location. J Surg Res 175:12-17, 2012 [Epub ahead of print]
11) 杉田 孝,下瀬省二,平尾 健・他:悪性軟部腫瘍に対する患肢温存術の臨床成績.関節外科21;1092-1097,2002
12) Weaver J, Downs-Kelly E, Goldblum JR, et al:Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms. Mod Pathol 21:943-949, 2008
13) Weaver J, Rao P, Goldblum JR, et al:Can MDM2 analytical tests performed on core needle biopsy be relied upon to diagnose well-differentiated liposarcoma? Mod Pathol 23:1301-1306, 2010
14) Weiss SW, Goldblum JR:Enzinger and Weiss's Soft Tissue Tumors. 5th ed, Mosby, St. Louis, pp477-493, 2008
15) Yoshimura N, Oka H, Muraki S, et al:Reference values for hand grip strength, muscle mass, walking time, and one-leg standing time as indices for locomotive syndrome and associated disability:the second survey of the ROAD study. J Orthop Sci 16:768-777, 2011 [Epub ahead of print]